-
1
المؤلفون: François-Xavier Danlos, Matthieu Texier, Bastien Job, Severine Mouraud, Lydie Cassard, Capucine Baldini, Andrea Varga, Andrey A. Yurchenko, Audrey Rabeau, Stéphane Champiat, Diane Letourneur, Delphine Bredel, Sandrine Susini, Yuna Blum, Aurelien Parpaleix, Cedric Parlavecchio, Lambros Tselikas, Jean-Eudes Fahrner, Anne-Gaelle Goubet, Mathieu Rouanne, Saloomeh Rafie, Alae Abbassi, Ines Kasraoui, Marie Breckler, Siham Farhane, Samy Ammari, Salim Laghouati, Anas Gazzah, Ludovic Lacroix, Benjamin Besse, Nathalie Droin, Marc Deloger, Sophie Cotteret, Julien Adam, Laurence Zitvogel, Sergey I. Nikolaev, Nathalie Chaput, Christophe Massard, Jean-Charles Soria, Carlos Gomez-Roca, Gerard Zalcman, David Planchard, Aurelien Marabelle
المساهمون: Institut Gustave Roussy (IGR), Immunologie anti-tumorale et immunothérapie des cancers (ITIC), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, École normale supérieure de Lyon (ENS de Lyon), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon, Institut de Génétique et Développement de Rennes (IGDR), Université de Rennes (UR)-Centre National de la Recherche Scientifique (CNRS)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Département d'imagerie médicale [Gustave Roussy], Département de biologie et pathologie médicales [Gustave Roussy], Département de médecine oncologique, CRLCC Paul Strauss, Dynamique moléculaire de la transformation hématopoïétique (Dynamo), Département de médecine oncologique [Gustave Roussy], Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Département d’Innovation Thérapeutique et essais précoces [Gustave Roussy] (DITEP), Institut Claudius Regaud
المصدر: Cancer Discovery
Cancer Discovery, 2023, pp.OF1-OF22. ⟨10.1158/2159-8290.CD-22-0886⟩مصطلحات موضوعية: Oncology, [SDV.CAN]Life Sciences [q-bio]/Cancer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5017878bdc841681bdf4cd403e9f0c10Test
https://doi.org/10.1158/2159-8290.cd-22-0886Test -
2
المؤلفون: Cécile Le Péchoux, Anne-Marie C. Dingemans, Laura Mezquita, Boris Duchemann, Emmanuèle Lechapt, Clarisse Audigier-Valette, Clemence Henon, Sophie Cousin, Lizza E.L. Hendriks, Samy Ammari, David Planchard, Anas Gazzah, Corentin Lefebvre, Caroline Caramella, Dirk De Ruysscher, Roberto Ferrara, Julien Mazieres, Angela Botticella, Edouard Auclin, Julien Adam, Audrey Rabeau, Sylvestre Le Moulec, Benjamin Besse
المساهمون: Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie
المصدر: Journal of Thoracic Oncology, 14(7), 1244-1254. Elsevier Science
مصطلحات موضوعية: 0301 basic medicine, Male, Lung Neoplasms, Programmed Cell Death 1 Receptor, Pembrolizumab, NSCLC, Gastroenterology, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, Disease specific Graded Prognostic Assessment, Carcinoma, Non-Small-Cell Lung, Checkpoint inhibition, Medicine, Aged, 80 and over, DOCETAXEL, Brain Neoplasms, Middle Aged, Prognosis, OPEN-LABEL, Survival Rate, Oncology, Docetaxel, 030220 oncology & carcinogenesis, Cohort, Carcinoma, Squamous Cell, Female, Nivolumab, medicine.drug, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Adenocarcinoma of Lung, survival, 03 medical and health sciences, Internal medicine, PATIENTS PTS, Humans, Lung cancer, PEMBROLIZUMAB, Pseudoprogression, Aged, Retrospective Studies, business.industry, Proportional hazards model, NIVOLUMAB, Brain metastases, medicine.disease, EFFICACY, Confidence interval, LIFE, 030104 developmental biology, business, SYSTEM, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71577960fdcb3b6db9e0ec054f54aa9Test
https://doi.org/10.1016/j.jtho.2019.02.009Test -
3
المؤلفون: Valérie Gounant, Delphine Carmier, Alexandra Langlais, Lionel Uwer, Denis Moro-Sibilot, Franck Morin, Olivier Molinier, José Hureaux, Pierre-Jean Souquet, Patrick Merle, Jean-Louis Pujol, Sébastien Bommart, Clarisse Audigier-Valette, Pierre Mourlanette, Florian Guisier, Aldo Renault, Martine Antoine, Jeannick Madelaine, Laurent Greillier, Marc G. Denis, Audrey Rabeau, J. Otto
المساهمون: Equipe Quantification en Imagerie Fonctionnelle (QuantIF-LITIS), Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Institut National des Sciences Appliquées (INSA)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Université Le Havre Normandie (ULH), Normandie Université (NU)-Institut national des sciences appliquées Rouen Normandie (INSA Rouen Normandie), Normandie Université (NU)
المصدر: Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2019, 14 (5), pp.903-913. ⟨10.1016/j.jtho.2019.01.008⟩مصطلحات موضوعية: Male, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Randomization, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Phases of clinical research, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, medicine, Clinical endpoint, Chemotherapy, Humans, Aged, Aged, 80 and over, Programmed cell death ligand 1, business.industry, SCLC, Middle Aged, Small Cell Lung Carcinoma, Confidence interval, 3. Good health, 030104 developmental biology, 030220 oncology & carcinogenesis, Toxicity, Female, Topotecan, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f0c334a072ea9fa844d16554706157Test
https://doi.org/10.1016/j.jtho.2019.01.008Test -
4
المؤلفون: Pauline Lamoureux, Denis Moro-Sibilot, Thomas Egenod, P. Bombaron, Melinda Daumont, Audrey Rabeau, Adrien Dixmier, Christophe Raspaud, Nicolas Benoit, Didier Debieuvre, N. Ozan, Juliette Dumanoir, Bernard Asselain, Virginie Westeel, C. Calvet, Clarisse Audigier-Valette, Dorothee Reynaud, Victoria Allan, Fabrice Barlesi, François-Emery Cotté, Maurice Pérol, Jean-Bernard Auliac, Jérôme Fayette, Jean-Luc Labourey, Myriam Locatelli Sanchez
المصدر: Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, medicine.medical_specialty, Lung Neoplasms, Immunology, Treatment of lung cancer, EVIDENS, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Immunology and Allergy, Humans, Prospective Studies, Lung cancer, RC254-282, non-small cell lung cancer, nivolumab, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC581-607, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, Observational study, observational study, France, Immunologic diseases. Allergy, Nivolumab, business, Back Matter
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3aa8e4cd6d1d9936466474b2b2ea83Test
https://pubmed.ncbi.nlm.nih.gov/33457089Test -
5
المؤلفون: Denis Moro-Sibilot, Guillaume Herbreteau, Olivier Molinier, José Hureaux, Patrick Merle, Jeannick Madelaine, Audrey Rabeau, J. Otto, Florian Guisier, Clarisse Audigier-Valette, Lionel Uwer, Valérie Gounant, Aldo Renault, Marc G. Denis, Laurent Greillier, Jean-Louis Pujol, Alexandra Langlais, Franck Morin, Pierre-Jean Souquet, Delphine Carmier
المساهمون: Centre hospitalier universitaire de Nantes (CHU Nantes), Intergroupe Francophone de Cancérologie Thoracique [Paris] (IFCT), Intergroupe Francophone de Cancérologie thoracique, Assistance Publique - Hôpitaux de Marseille (APHM), Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer - Hôpital Sainte-Musse, Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), UNICANCER, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), CHU Grenoble, Service de pneumologie, oncologie thoracique et soins intensifs respiratoires [Rouen], Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU), Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Service de pneumologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Service de pneumologie [Centre Hospitalier Lyon Sud - HCL], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Service d’oncologie thoracique et essais précoces [CHU Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Clermont-Ferrand, Centre Hospitalier Le Mans (CH Le Mans), Centre hospitalier de Pau, Service de pneumologie [Toulouse], CHU Toulouse [Toulouse]-Hôpital Larrey [Toulouse], CHU Toulouse [Toulouse], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Hôpital Charles Nicolle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Herrada, Anthony, Hôpital Charles Nicolle [Rouen]-CHU Rouen
المصدر: Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2020, 9 (12), pp.3861. ⟨10.3390/jcm9123861⟩
Journal of Clinical Medicine, Vol 9, Iss 3861, p 3861 (2020)
Journal of Clinical Medicine, 2020, 9 (12), pp.3861. ⟨10.3390/jcm9123861⟩
Volume 9
Issue 12مصطلحات موضوعية: Oncology, atezolizumab, medicine.medical_specialty, medicine.medical_treatment, lcsh:Medicine, [SDV.CAN]Life Sciences [q-bio]/Cancer, medicine.disease_cause, Article, 03 medical and health sciences, 0302 clinical medicine, Germline mutation, [SDV.CAN] Life Sciences [q-bio]/Cancer, Atezolizumab, Internal medicine, medicine, RB1, Progression-free survival, TP53, 030304 developmental biology, 0303 health sciences, Chemotherapy, Mutation, business.industry, lcsh:R, SCLC, General Medicine, Immunotherapy, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, ctDNA, NOTCH, 3. Good health, Clinical trial, 030220 oncology & carcinogenesis, Non small cell, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, mutation, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c50a707dbfc16b1eab6bacdf79ed4426Test
http://europepmc.org/articles/PMC7760916Test -
6
المؤلفون: Julien Adam, Diane Letourneur, François-Xavier Danlos, M. Texier, David Planchard, Gérard Zalcman, Aurelien Parpaleix, Bastien Job, Jean-Charles Soria, Audrey Rabeau, Severine Mouraud, Aurélien Marabelle, Nathalie Chaput-Gras, Andreea Varga, Christophe Massard, Salim Laghouati, Capucine Baldini, Delphine Bredel, Lydie Cassard, Nathalie Droin
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Myeloid, medicine.medical_treatment, Immunology, Pembrolizumab, Gastroenterology, chemistry.chemical_compound, Internal medicine, medicine, Immunology and Allergy, Mesothelioma, RC254-282, Pharmacology, Chemotherapy, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cancer, Immunotherapy, medicine.disease, medicine.anatomical_structure, Oncology, chemistry, Molecular Medicine, Nintedanib, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4f7125414e565bb9296abf308612513Test
https://doi.org/10.1136/jitc-2021-sitc2021.378Test -
7
المؤلفون: Carlos Gomez-Roca, Delphine Loirat, Bastien Cabarrou, Rodolphe Paulon, Nadia Munsch, Audrey Rabeau, Marie Viala, Jean-Pierre Delord, Thomas Filleron
المصدر: Investigational new drugs. 38(6)
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Immune checkpoint inhibitors, medicine.medical_treatment, Medical Oncology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Neoplasms, Medicine, Humans, Pharmacology (medical), In patient, Adverse effect, Immune Checkpoint Inhibitors, Pharmacology, Antitumor activity, Clinical Trials as Topic, business.industry, Clinical trial, Safety profile, 030104 developmental biology, Clinical research, 030220 oncology & carcinogenesis, Immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce22e28f708a83eec6881df03eddc551Test
https://pubmed.ncbi.nlm.nih.gov/32383099Test -
8
المؤلفون: Lydie Cassard, F.X. Danlos, Severine Mouraud, Diane Letourneur, Aurélien Marabelle, Bastien Job, Andreea Varga, Christophe Massard, David Planchard, Salim Laghouati, Julien Adam, J-C. Soria, M. Texier, Audrey Rabeau, Gérard Zalcman, Capucine Baldini, Nathalie Droin, Nathalie Chaput, A. Parpaleix, Delphine Bredel
المصدر: Annals of Oncology. 32:S1198
مصطلحات موضوعية: Drug supply, Coronavirus disease 2019 (COVID-19), business.industry, Best Overall Response, Hematology, Advanced malignant mesothelioma, Disease control, Treatment efficacy, Management, Principal (commercial law), Oncology, Medicine, business, Immune Factors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::307317571c98ff3b663f0fc8f8e81e8cTest
https://doi.org/10.1016/j.annonc.2021.08.1976Test -
9
المؤلفون: Caroline Caramella, Valérie Gounant, Laura Mezquita, Christophe Massard, Andreea Varga, G. Zalcman, Aurélien Marabelle, Xavier Paoletti, P. Vuagnat, Patricia Martin-Romano, Audrey Rabeau, Capucine Baldini, David Planchard, Carlos Gomez-Roca, Stéphane Champiat, Benjamin Besse, J-C. Soria, J-M. Michot, Samy Ammari
المصدر: Journal of Thoracic Oncology. 14:S268
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Pleural mesothelioma, Pembrolizumab, chemistry.chemical_compound, Refractory, chemistry, Internal medicine, medicine, Nintedanib, In patient, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f831acb0d1cb510644796f9dc5df868cTest
https://doi.org/10.1016/j.jtho.2019.08.537Test -
10
المؤلفون: Audrey Rabeau, Julien Mazieres, Florent Puisset, Marie Noëlle Paludetto, Audrey Martel, Laurence Bigay-Game, Jean Marie Canonge, Sophie Perriat
المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 27(5)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lung Neoplasms, Urology, Renal function, Antineoplastic Agents, Nephrotoxicity, Cohort Studies, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Medicine, Humans, 030212 general & internal medicine, Lung cancer, Infusions, Intravenous, Aged, Retrospective Studies, Cisplatin, Aged, 80 and over, business.industry, Incidence, Retrospective cohort study, Middle Aged, medicine.disease, Regimen, Oncology, 030220 oncology & carcinogenesis, Cohort, Fluid Therapy, Female, Kidney Diseases, business, Cohort study, medicine.drug, Glomerular Filtration Rate
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0804409a1f5b3fc30e16fc417838b2eTest
https://pubmed.ncbi.nlm.nih.gov/30120556Test
